EviCure
Ness Ziona
About EviCure
EviCure is a biotechnology firm that develops extracellular vesicle (EV)--based platform technology for cancer treatment.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $1.4M
- Last round: Series Unknown (Apr 2025)
- Website: evicure.bio
- Phone: 054-425-7382
Industries & Categories
Biotechnology, Health Diagnostics, Product Research
Social Profiles
Canonical: https://fsome.com/organization/evicure-138004 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.